Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses:        
General and administrative $ 1,423,228 $ 2,164,560 $ 5,301,934 $ 6,081,362
Research and development 1,581,376 1,624,766 5,688,478 4,749,217
Loss from operations (3,004,604) (3,789,326) (10,990,412) (10,830,579)
Other income (expense):        
Change in fair value of warrant liabilities (70,306) 44,996 (79,212) 111,552
Interest and dividends, net 75,076 131,740 342,701 242,543
Other income, net 4,770 176,736 263,489 354,095
Loss before income taxes (2,999,834) (3,612,590) (10,726,923) (10,476,484)
Provision for income taxes
Net loss from continuing operations (2,999,834) (3,612,590) (10,726,923) (10,476,484)
Net loss from discontinued operations, net of tax (437,015)
Net loss $ (2,999,834) $ (3,612,590) $ (10,726,923) $ (10,913,499)
Weighted-average common shares outstanding, basic (in Shares) 1,044,144 1,258,050 1,043,315 1,289,201
Weighted-average common shares outstanding, diluted (in Shares) 1,044,144 1,258,050 1,043,315 1,289,201
Basic loss per share from continuing operations (in Dollars per share) $ (2.87) $ (2.87) $ (10.28) $ (8.13)
Diluted loss per share from continuing operations (in Dollars per share) (2.87) (2.87) (10.28) (8.13)
Basic loss per share from discontinuing operations (in Dollars per share) (0.34)
Diluted loss per share from discontinuing operations (in Dollars per share) $ (0.34)
Comprehensive loss:        
Net loss $ (2,999,834) $ (3,612,590) $ (10,726,923) $ (10,913,499)
Foreign currency translation (27,133) (4,256) (30,665) (7,056)
Comprehensive loss $ (3,026,967) $ (3,616,846) $ (10,757,588) $ (10,920,555)